Prostate cancer and bone health
Not Applicable
- Conditions
- Health Condition 1: null- Prostate cancer patients who presents to KGMU for treatment will be enrolled in the study.
- Registration Number
- CTRI/2017/08/009451
- Lead Sponsor
- King George Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1.Diagnosed cases of prostate cancer
Exclusion Criteria
1.Other active malignancy
2.Metabolic bone disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate the bone health, FRAX score and quality of life in carcinoma prostate patients. <br/ ><br>2. To reduce their morbidity related to carcinoma prostate by delaying skeletal related events and to improve overall quality of life. <br/ ><br>Timepoint: between january 2017 to december 2018 <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.To evaluate mortality and morbidity in prostate cancer patients. <br/ ><br>2. To evaluate adverse events related to androgen deprivation therapy.Timepoint: between january 2017 to december 2018